Central Alerting System


Reference:

Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)



Reference Alert Title Originated ByIssue DateStatus
CEM/CMO/2022/013 Influenza season 2022/2023: Use of antiviral medicines CMO Messaging 24-Nov-2022 Issued
NatPSA/2022/009/MHRA Prenoxad 1mg/ml Solution for Injection in a pre-filled syringe, Macarthys Laboratories, (Aurum Pharm ... National Patient Safety Alert - MHRA 10-Nov-2022 Issued
NatPSA/2022/008/MHRA Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma ... National Patient Safety Alert - MHRA 21-Oct-2022 Issued
CEM/CMO/2022/012 Tecovirimat as a treatment for patients hospitalised due to Monkeypox viral infection CMO Messaging 20-Sep-2022 Issued
NatPSA/2022/007/MHRA Recall of Mexiletine hydrochloride 50mg, 100mg and 200mg Hard Capsules, Clinigen Healthcare Ltd due ... National Patient Safety Alert - MHRA 04-Aug-2022 Issued
NatPSA/2022/006/DHSC Shortage of alteplase and tenecteplase injections National Patient Safety Alert - DHSC 03-Aug-2022 Issued
CEM/CMO/2022/011 Commencement of a Palivizumab Passive Immunisation Programme Against Respiratory Syncytial Virus (RS ... CMO Messaging 04-Jul-2022 Issued
NatPSA/2022/005/UKHSA Contamination of hygiene products with Pseudomonas aeruginosa National Patient Safety Alert - UKHSA 24-Jun-2022 Issued
CEM/CMO/2022/010 Antivirals or Neutralising Antibodies for Non-Hospitalised Patients with COVID-19 CMO Messaging 30-May-2022 Issued
CEM/CMO/2022/009 Antivirals or Neutralising Monoclonal Antibodies in the Treatment of Hospital-Onset COVID-19 CMO Messaging 30-May-2022 Issued
12345678910...


* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert can be found in this update.

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency